Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2020 Filed Jul 22, 2020 21:17 UTC |
COYLE MICHAEL JDirector
|
GrantCommon Stock | 1,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-021977 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,461 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:15 UTC |
BURZIK CATHERINE MDirector
|
GrantCommon Stock | 1,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-021975 · form4.xml · nonDerivative · entry 1 BURZIK CATHERINE M · CIK 0001261141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,738 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:11 UTC |
ABERNATHY ROBERT EDirector
|
GrantCommon Stock | 1,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-021973 · form4.xml · nonDerivative · entry 1 ABERNATHY ROBERT E · CIK 0001222888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,048 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:20 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 5,084 | $87.79 | $446,324.36 |
DisclosureSEC source: 0001127602-20-020895 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,310 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 1,300 | $92.14 | $119,782.00 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 6 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,173 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.24, inclusive. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 6,961 | $91.34 | $635,817.74 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 5 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,473 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.93, inclusive. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 5,175 | $90.32 | $467,406.00 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 4 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,434 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.93 to $90.93, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4 F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 6,869 | $91.53 | $628,719.57 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 6 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,487 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 1,209 | $92.09 | $111,336.81 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 6 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.97 to $92.24, inclusive. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 6,146 | $91.38 | $561,621.48 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 5 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,707 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.95, inclusive. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 5,259 | $90.36 | $475,203.24 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 4 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,853 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.94 to $90.94, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 21:55 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 3,040 | $91.53 | $278,251.20 |
DisclosureSEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 5 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,849 F4 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 10,578 | $87.71 | $927,796.38 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 3 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,609 F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,889 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · derivative · entry 7 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890 Underlying: Common Stock · 2,889 shares Expires 2024-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 4,005 | $90.00 | $360,450.00 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 5 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,356 F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
Exercise / conversionCommon Stock | 2,889 | $41.64 | $120,297.96 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 4 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 4,417 | $87.71 | $387,415.07 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 3 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,472 F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 9,720 | $87.71 | $852,541.20 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 3 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,112 F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:55 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 1,282 | $87.71 | $112,444.22 |
DisclosureSEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 4 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,889 F5 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F5 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:55 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 92 | $87.16 | $8,018.72 |
DisclosureSEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 3 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,171 F4 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:51 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 45,723 | $87.71 | $4,010,364.33 |
DisclosureSEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 3 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,394 F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 203 | $89.29 | $18,125.87 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 2 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,187 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:19 UTC |
Basil Michelle LEVP and General Counsel
|
GrantCommon Stock | 24,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 1 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,390 F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 111 | $89.29 | $9,911.19 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 2 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,889 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:53 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
GrantCommon Stock | 11,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 1 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 197 | $89.29 | $17,590.13 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 2 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,832 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:16 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
GrantCommon Stock | 22,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 1 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,029 F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:55 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 42 | $82.29 | $3,456.18 |
DisclosureSEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,263 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:55 UTC |
Goldstein DanVP, Corporate Controller
|
GrantCommon Stock | 4,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,305 F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:51 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 1,294 | $89.29 | $115,541.26 |
DisclosureSEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 2 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,117 F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:51 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantCommon Stock | 102,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,411 F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:04 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 187 | $97.19 | $18,174.53 |
DisclosureSEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 4 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,983 F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:04 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,106 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001127602-20-019382 · form4.xml · derivative · entry 5 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107 Underlying: Common Stock · 1,106 shares Expires 2024-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:04 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 1,106 | $99.09 | $109,593.54 |
DisclosureSEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 3 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,170 F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:04 UTC |
Goldstein DanVP, Corporate Controller
|
Exercise / conversionCommon Stock | 1,106 | $41.64 | $46,053.84 |
DisclosureSEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:04 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 83 | $97.03 | $8,053.49 |
DisclosureSEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 1 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,170 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:59 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
SaleCommon Stock | 324 | $97.03 | $31,437.72 |
DisclosureSEC source: 0001127602-20-019381 · form4.xml · nonDerivative · entry 1 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:57 UTC |
Basil Michelle LEVP and General Counsel
|
SaleCommon Stock | 687 | $97.03 | $66,659.61 |
DisclosureSEC source: 0001127602-20-019379 · form4.xml · nonDerivative · entry 1 Basil Michelle L · CIK 0001699629 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,376 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:54 UTC |
Burke William P. Mr.EVP, Chief Financial Officer
|
SaleCommon Stock | 639 | $97.03 | $62,002.17 |
DisclosureSEC source: 0001127602-20-019376 · form4.xml · nonDerivative · entry 1 Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,695 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:52 UTC |
Simon, ChristopherDirector · President & CEO
|
SaleCommon Stock | 2,920 | $97.03 | $283,327.60 |
DisclosureSEC source: 0001127602-20-019374 · form4.xml · nonDerivative · entry 1 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,347 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 18, 2020 Filed May 19, 2020 23:06 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 49,105 | $0.00 Strike: $103.37 | $0.00 |
DisclosureSEC source: 0001127602-20-017282 · form4.xml · derivative · entry 3 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,105 Underlying: Common Stock · 49,105 shares Expires 2027-05-18 F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 18, 2020 Filed May 19, 2020 23:06 UTC |
Simon, ChristopherDirector · President & CEO
|
GrantCommon Stock | 14,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-017282 · form4.xml · nonDerivative · entry 2 Simon, Christopher · CIK 0001674993 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,267 F3 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F3 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F4 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F2 · balance_after: This number includes unvested RSUs previously reported as well as 193 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2020. Read SEC document |
| May 18, 2020 Filed May 19, 2020 22:10 UTC |
Goldstein DanVP, Corporate Controller
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 1,841 | $0.00 Strike: $103.37 | $0.00 |
DisclosureSEC source: 0001127602-20-017278 · form4.xml · derivative · entry 4 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,841 Underlying: Common Stock · 1,841 shares Expires 2027-05-18 F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 18, 2020 Filed May 19, 2020 22:10 UTC |
Goldstein DanVP, Corporate Controller
|
GrantCommon Stock | 544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-017278 · form4.xml · nonDerivative · entry 3 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,253 F4 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F4 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F5 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 18, 2020 Filed May 19, 2020 22:10 UTC |
Goldstein DanVP, Corporate Controller
|
SaleCommon Stock | 101 | $101.72 | $10,273.72 |
DisclosureSEC source: 0001127602-20-017278 · form4.xml · nonDerivative · entry 2 Goldstein Dan · CIK 0001722327 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,709 F3 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:51 UTC |
Llorens JosepSVP, Global Manufacturing
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,728 | $0.00 Strike: $103.37 | $0.00 |
DisclosureSEC source: 0001127602-20-017270 · form4.xml · derivative · entry 3 Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,728 Underlying: Common Stock · 5,728 shares Expires 2027-05-18 F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:51 UTC |
Llorens JosepSVP, Global Manufacturing
|
GrantCommon Stock | 1,692 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-017270 · form4.xml · nonDerivative · entry 2 Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,355 F3 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F3 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F4 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F2 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:42 UTC |
Lingamneni AnilaEVP, Chief Technology Officer
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,092 | $0.00 Strike: $103.37 | $0.00 |
DisclosureSEC source: 0001127602-20-017268 · form4.xml · derivative · entry 2 Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,092 Underlying: Common Stock · 4,092 shares Expires 2027-05-18 F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:42 UTC |
Lingamneni AnilaEVP, Chief Technology Officer
|
GrantCommon Stock | 1,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-017268 · form4.xml · nonDerivative · entry 1 Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,390 F1 · kind: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:34 UTC |
Scanlan JacquelineSVP, Global Human Resources
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,319 | $0.00 Strike: $103.37 | $0.00 |
DisclosureSEC source: 0001127602-20-017266 · form4.xml · derivative · entry 3 Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,319 Underlying: Common Stock · 5,319 shares Expires 2027-05-18 F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.